ARGX vs. ATR: A Head-to-Head Stock Comparison

Updated on October 14, 2025

Here’s a clear look at ARGX and ATR, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

ARGX trades as an American Depositary Receipt (ADR), offering U.S. investors a convenient way to access its foreign-listed shares. In contrast, ATR is a standard domestic listing.

Symbol	ARGX	ATR
Company Name	argenx SE	AptarGroup, Inc.
Country	Netherlands	United States
GICS Sector	Health Care	Materials
GICS Industry	Biotechnology	Containers & Packaging
Market Capitalization	49.19 billion USD	8.67 billion USD
Exchange	NasdaqGS	NYSE
Listing Date	May 18, 2017	April 23, 1993
Security Type	ADR	Common Stock

Historical Performance

This chart compares the performance of ARGX and ATR by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

ARGX vs. ATR: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

Symbol	ARGX	ATR
5-Day Price Return	2.66%	-1.18%
13-Week Price Return	46.02%	-17.60%
26-Week Price Return	30.48%	-11.48%
52-Week Price Return	39.71%	-17.06%
Month-to-Date Return	10.01%	-1.53%
Year-to-Date Return	13.17%	-16.23%
10-Day Avg. Volume	0.09M	0.39M
3-Month Avg. Volume	0.10M	0.43M
3-Month Volatility	38.39%	24.82%
Beta	0.95	0.53

Profitability

Return on Equity (TTM)

ARGX

17.59%

Biotechnology Industry

Max: 97.92%
Q3: 11.99%
Median: -19.30%
Q1: -51.29%
Min: -132.03%

In the upper quartile for the Biotechnology industry, ARGX’s Return on Equity of 17.59% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

ATR

15.30%

Containers & Packaging Industry

Max: 36.99%
Q3: 19.86%
Median: 10.47%
Q1: 6.76%
Min: -0.20%

ATR’s Return on Equity of 15.30% is on par with the norm for the Containers & Packaging industry, indicating its profitability relative to shareholder equity is typical for the sector.

ARGX vs. ATR: A comparison of their Return on Equity (TTM) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Net Profit Margin (TTM)

ARGX

-23.60%

Biotechnology Industry

Max: 73.34%
Q3: 18.98%
Median: -12.96%
Q1: -105.72%
Min: -259.82%

ARGX has a negative Net Profit Margin of -23.60%, indicating the company is operating at a net loss as its expenses exceeded its revenues.

ATR

10.86%

Containers & Packaging Industry

Max: 10.84%
Q3: 8.25%
Median: 4.91%
Q1: 3.65%
Min: -0.12%

ATR’s Net Profit Margin of 10.86% is exceptionally high, placing it well beyond the typical range for the Containers & Packaging industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.

ARGX vs. ATR: A comparison of their Net Profit Margin (TTM) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Operating Profit Margin (TTM)

ARGX

-40.34%

Biotechnology Industry

Max: 78.85%
Q3: 21.90%
Median: -13.30%
Q1: -109.94%
Min: -278.10%

ARGX has a negative Operating Profit Margin of -40.34%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.

ATR

14.26%

Containers & Packaging Industry

Max: 22.03%
Q3: 13.09%
Median: 8.06%
Q1: 6.46%
Min: -0.07%

An Operating Profit Margin of 14.26% places ATR in the upper quartile for the Containers & Packaging industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

ARGX vs. ATR: A comparison of their Operating Profit Margin (TTM) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Profitability at a Glance

Symbol	ARGX	ATR
Return on Equity (TTM)	17.59%	15.30%
Return on Assets (TTM)	15.24%	8.50%
Net Profit Margin (TTM)	-23.60%	10.86%
Operating Profit Margin (TTM)	-40.34%	14.26%
Gross Profit Margin (TTM)	90.83%	38.32%

Financial Strength

Current Ratio (MRQ)

ARGX

5.60

Biotechnology Industry

Max: 16.97
Q3: 8.39
Median: 4.11
Q1: 2.64
Min: 0.74

ARGX’s Current Ratio of 5.60 aligns with the median group of the Biotechnology industry, indicating that its short-term liquidity is in line with its sector peers.

ATR

1.21

Containers & Packaging Industry

Max: 1.96
Q3: 1.45
Median: 1.33
Q1: 1.09
Min: 0.87

ATR’s Current Ratio of 1.21 aligns with the median group of the Containers & Packaging industry, indicating that its short-term liquidity is in line with its sector peers.

ARGX vs. ATR: A comparison of their Current Ratio (MRQ) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Debt-to-Equity Ratio (MRQ)

ARGX

0.01

Biotechnology Industry

Max: 1.92
Q3: 0.79
Median: 0.12
Q1: 0.00
Min: 0.00

ARGX’s Debt-to-Equity Ratio of 0.01 is typical for the Biotechnology industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

ATR

0.40

Containers & Packaging Industry

Max: 4.15
Q3: 2.03
Median: 1.20
Q1: 0.53
Min: 0.23

Falling into the lower quartile for the Containers & Packaging industry, ATR’s Debt-to-Equity Ratio of 0.40 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.

ARGX vs. ATR: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Interest Coverage Ratio (TTM)

ARGX

-81.88

Biotechnology Industry

Max: 72.37
Q3: 1.03
Median: -9.59
Q1: -65.05
Min: -163.11

ARGX has a negative Interest Coverage Ratio of -81.88. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.

ATR

16.67

Containers & Packaging Industry

Max: 13.16
Q3: 8.10
Median: 3.38
Q1: 2.83
Min: 1.06

With an Interest Coverage Ratio of 16.67, ATR demonstrates a superior capacity to service its debt, placing it well above the typical range for the Containers & Packaging industry. This stems from either robust earnings or a conservative debt load.

ARGX vs. ATR: A comparison of their Interest Coverage Ratio (TTM) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Financial Strength at a Glance

Symbol	ARGX	ATR
Current Ratio (MRQ)	5.60	1.21
Quick Ratio (MRQ)	4.92	0.83
Debt-to-Equity Ratio (MRQ)	0.01	0.40
Interest Coverage Ratio (TTM)	-81.88	16.67

Growth

Revenue Growth

ARGX vs. ATR: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

ARGX vs. ATR: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

ARGX

0.00%

Biotechnology Industry

Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

ARGX currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

ATR

1.38%

Containers & Packaging Industry

Max: 7.14%
Q3: 4.65%
Median: 3.69%
Q1: 2.00%
Min: 0.00%

ATR’s Dividend Yield of 1.38% is in the lower quartile for the Containers & Packaging industry. This suggests the company’s strategy likely favors retaining earnings for growth over providing a high dividend income.

ARGX vs. ATR: A comparison of their Dividend Yield (TTM) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Dividend Payout Ratio (TTM)

ARGX

0.00%

Biotechnology Industry

Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

ARGX has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

ATR

30.61%

Containers & Packaging Industry

Max: 222.75%
Q3: 132.16%
Median: 65.79%
Q1: 28.53%
Min: 0.00%

ATR’s Dividend Payout Ratio of 30.61% is within the typical range for the Containers & Packaging industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

ARGX vs. ATR: A comparison of their Dividend Payout Ratio (TTM) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Dividend at a Glance

Symbol	ARGX	ATR
Dividend Yield (TTM)	0.00%	1.38%
Dividend Payout Ratio (TTM)	0.00%	30.61%

Valuation

Price-to-Earnings Ratio (TTM)

ARGX

37.96

Biotechnology Industry

Max: 40.44
Q3: 39.37
Median: 22.12
Q1: 15.76
Min: 3.48

ARGX’s P/E Ratio of 37.96 is within the middle range for the Biotechnology industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

ATR

22.12

Containers & Packaging Industry

Max: 24.22
Q3: 20.28
Median: 17.07
Q1: 15.06
Min: 7.79

A P/E Ratio of 22.12 places ATR in the upper quartile for the Containers & Packaging industry. This high valuation relative to peers suggests the market holds elevated expectations for the company’s future growth.

ARGX vs. ATR: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Price-to-Sales Ratio (TTM)

ARGX

29.31

Biotechnology Industry

Max: 92.67
Q3: 41.36
Median: 8.45
Q1: 4.46
Min: 0.97

ARGX’s P/S Ratio of 29.31 aligns with the market consensus for the Biotechnology industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

ATR

2.40

Containers & Packaging Industry

Max: 1.99
Q3: 1.17
Median: 0.94
Q1: 0.55
Min: 0.31

With a P/S Ratio of 2.40, ATR trades at a valuation that eclipses even the highest in the Containers & Packaging industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.

ARGX vs. ATR: A comparison of their Price-to-Sales Ratio (TTM) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Price-to-Book Ratio (MRQ)

ARGX

5.47

Biotechnology Industry

Max: 22.72
Q3: 10.68
Median: 4.55
Q1: 2.44
Min: 0.59

ARGX’s P/B Ratio of 5.47 is within the conventional range for the Biotechnology industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

ATR

3.83

Containers & Packaging Industry

Max: 4.79
Q3: 3.32
Median: 2.14
Q1: 1.60
Min: 0.89

ATR’s P/B Ratio of 3.83 is in the upper tier for the Containers & Packaging industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

ARGX vs. ATR: A comparison of their Price-to-Book Ratio (MRQ) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Valuation at a Glance

Symbol	ARGX	ATR
Price-to-Earnings Ratio (TTM)	37.96	22.12
Price-to-Sales Ratio (TTM)	29.31	2.40
Price-to-Book Ratio (MRQ)	5.47	3.83
Price-to-Free Cash Flow Ratio (TTM)	--	25.35